ICICI Securities maintains a 'BUY' rating on Chemplast Sanmar with a target of Rs 300, betting on a business turnaround despite a difficult start to FY27. The company recently reported a Q1 EBITDA loss of ₹115 crore on revenues of ₹1,125 crore. Investors are now watching for potential relief from import duties and scaling in the specialty chemicals segment.
ICICI Securities has kept its 'BUY' rating on Chemplast Sanmar, setting a target price of Rs 300. This outlook stands in contrast to the company's recent financial performance, as it navigates a challenging period for the chemical sector. The brokerage firm is anticipating a recovery in volumes and margins, though current market conditions remain under pressure.
Financial Context and Market Reaction
The company's performance in the first quarter of fiscal year 2027 reflects the difficulties faced by the chemical industry. Chemplast Sanmar reported consolidated revenues of ₹1,125 crore, but it swung to an EBITDA loss of ₹115 crore. The stock price has faced significant selling pressure, trading near ₹182, which is a steep decline from its 52-week high of ₹460.80. This performance gap suggests that the market is currently pricing in the immediate operational headwinds rather than the potential recovery the brokerage expects later in the year.
The Brokerage's Bullish Case
The optimism from ICICI Securities is primarily based on the expectation of normalcy in operations starting August 2026. The broker points to a few specific factors that could help the company. First, there is the potential for the implementation of anti-dumping duties (ADD) on Paste-PVC, which could protect domestic margins and allow for better pricing. Second, the company’s Custom Manufactured Chemicals Division (CMCD) remains a key focus area. The upcoming commissioning of the R-32 plant and an existing order book of 14 commercialized products are seen as long-term growth drivers that could reduce the company's reliance on commodity chemicals.
Challenges and Risks for Investors
While the brokerage sees a path to recovery, investors must be aware of the ongoing risks that have hurt the company recently. The primary headwind has been the elevated cost of Vinyl Chloride Monomer (VCM), a key raw material for its PVC business. When raw material costs rise and demand remains weak, as seen in the S-PVC and bulk chemical segments, margins are quickly squeezed.
Another significant risk is the execution of the CMCD segment's growth plans. While the long-term outlook is positive, the company needs to prove that it can scale these specialty products without delays. Furthermore, the company’s reliance on regulatory intervention, such as the implementation of anti-dumping duties, introduces a layer of uncertainty. If these policy changes are delayed or do not meet expectations, the financial turnaround may take longer than anticipated.
What Investors Should Track Next
The key monitorables for shareholders will be the actual volume recovery in the coming months and the status of anti-dumping duty implementation for Paste-PVC. Additionally, management commentary regarding the R-32 plant commissioning and any signs of stabilization in raw material costs will be crucial indicators of whether the company can move back toward profitability in the subsequent quarters.